Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Analysis of the intricate relationship between chronic inflammation and cancer
Edna Zhi Pei Chai, Kodappully Sivaraman Siveen, Muthu K. Shanmugam, et al.
Biochemical Journal (2015) Vol. 468, Iss. 1, pp. 1-15
Closed Access | Times Cited: 188

Showing 1-25 of 188 citing articles:

Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
Inés Mármol, Cristina Sánchez‐de‐Diego, Alberto Pradilla-Dieste, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 1, pp. 197-197
Open Access | Times Cited: 1258
The Role of Resveratrol in Cancer Therapy
Jeong‐Hyeon Ko, Gautam Sethi, Jae‐Young Um, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 12, pp. 2589-2589
Open Access | Times Cited: 657
Resolution of inflammation: An organizing principle in biology and medicine
Dipak Panigrahy, Molly M. Gilligan, Charles N. Serhan, et al.
Pharmacology & Therapeutics (2021) Vol. 227, pp. 107879-107879
Closed Access | Times Cited: 239
Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights
Diego de Sá Coutinho, Marcos Tadeu Tavares Pacheco, Rudimar Luiz Frozza, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 6, pp. 1812-1812
Open Access | Times Cited: 235
Chronic and Cycling Hypoxia: Drivers of Cancer Chronic Inflammation through HIF-1 and NF-κB Activation: A Review of the Molecular Mechanisms
Jan Korbecki, Donata Simińska, Magdalena Gąssowska-Dobrowolska, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10701-10701
Open Access | Times Cited: 227
Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds
Muthu K. Shanmugam, Jong Hyun Lee, Edna Zhi Pei Chai, et al.
Seminars in Cancer Biology (2016) Vol. 40-41, pp. 35-47
Closed Access | Times Cited: 217
Pro-Apoptotic and Anti-Cancer Properties of Diosgenin: A Comprehensive and Critical Review
Gautam Sethi, Muthu K. Shanmugam, Sudha Warrier, et al.
Nutrients (2018) Vol. 10, Iss. 5, pp. 645-645
Open Access | Times Cited: 217
Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
Muthu K. Shanmugam, Sudha Warrier, Alan Prem Kumar, et al.
Current Vascular Pharmacology (2017) Vol. 15, Iss. 6
Closed Access | Times Cited: 191
An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases
Nand Kishor Roy, Parama Dey, Kishore Banik, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4101-4101
Open Access | Times Cited: 185
Molecular mechanisms of action of hesperidin in cancer: Recent trends and advancements
Vaishali Aggarwal, Hardeep Singh Tuli, Falak Thakral, et al.
Experimental Biology and Medicine (2020) Vol. 245, Iss. 5, pp. 486-497
Open Access | Times Cited: 181
Evidence for the Involvement of the Master Transcription Factor NF-κB in Cancer Initiation and Progression
Yu Puar, Muthu K. Shanmugam, Lu Fan, et al.
Biomedicines (2018) Vol. 6, Iss. 3, pp. 82-82
Open Access | Times Cited: 176
Multifaceted Role of PARP-1 in DNA Repair and Inflammation: Pathological and Therapeutic Implications in Cancer and Non-Cancer Diseases
Simonetta Pazzaglia, Claudio Pioli
Cells (2019) Vol. 9, Iss. 1, pp. 41-41
Open Access | Times Cited: 172
Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model
Chulwon Kim, Seok‐Geun Lee, Woong Mo Yang, et al.
Cancer Letters (2018) Vol. 431, pp. 123-141
Closed Access | Times Cited: 166
Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets
Kishore Banik, Abhishek Manoj Ranaware, V A Deshpande, et al.
Pharmacological Research (2019) Vol. 144, pp. 192-209
Closed Access | Times Cited: 165
Focus on Formononetin: Anticancer Potential and Molecular Targets
Samantha Ong, Muthu K. Shanmugam, Lu Fan, et al.
Cancers (2019) Vol. 11, Iss. 5, pp. 611-611
Open Access | Times Cited: 159
Methionine Restriction and Cancer Biology
Desiree Wanders, Katherine Hobson, Xiangming Ji
Nutrients (2020) Vol. 12, Iss. 3, pp. 684-684
Open Access | Times Cited: 148
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review
Yu Li, Cangang Zhang, Aimin Jiang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 30
Anti-Cancer Activity of Derivatives of 1,3,4-Oxadiazole
Teresa Glomb, Karolina Szymankiewicz, Piotr Świątek
Molecules (2018) Vol. 23, Iss. 12, pp. 3361-3361
Open Access | Times Cited: 149
Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer
Abhishek Manoj Ranaware, Kishore Banik, V A Deshpande, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 8, pp. 2362-2362
Open Access | Times Cited: 146
Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2
Emily C. Graff, Han Fang, Desiree Wanders, et al.
Metabolism (2015) Vol. 65, Iss. 2, pp. 102-113
Closed Access | Times Cited: 143
FBXW7 in Cancer: What Has Been Unraveled Thus Far?
Bethsebie Lalduhsaki Sailo, Kishore Banik, Sosmitha Girisa, et al.
Cancers (2019) Vol. 11, Iss. 2, pp. 246-246
Open Access | Times Cited: 142
Functions and Malfunctions of Mammalian DNA-Cytosine Deaminases
Sachini U. Siriwardena, Kang Chen, Ashok S. Bhagwat
Chemical Reviews (2016) Vol. 116, Iss. 20, pp. 12688-12710
Open Access | Times Cited: 130
Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinoma
Jong Hyun Lee, Chakrabhavi Dhananjaya Mohan, Amudha Deivasigamani, et al.
Journal of Advanced Research (2020) Vol. 26, pp. 83-94
Open Access | Times Cited: 121
Potential Anti-Inflammatory and Anti-Cancer Properties of Farnesol
Young Yun Jung, Sun Tae Hwang, Gautam Sethi, et al.
Molecules (2018) Vol. 23, Iss. 11, pp. 2827-2827
Open Access | Times Cited: 120
Potential role of genipin in cancer therapy
Muthu K. Shanmugam, Hongyuan Shen, Feng Ru Tang, et al.
Pharmacological Research (2018) Vol. 133, pp. 195-200
Closed Access | Times Cited: 119
Page 1 - Next Page

Scroll to top